山田健人

ヤマダタケト | YAMADA Taketo

所属機関・部署：
職名：教授

研究分野 (4件)：その他 , 医療薬学 , 実験病理学 , 人体病理学

研究キーワード (8件)： molecular pathology , cancer , 分子病理学 , 疾患モデル , 疾患モデル , 分子標的療法 , 分子標的療法 , がん

競争的資金等の研究課題 (51件)：

全件表示

論文 (186件)：

Hattori Y, Miyakawa Y, Yokoyama K, Yamada T, Du W, Jinzaki M, Shinmoto H, Okamoto S. Prospective Study of Combination Therapy with Low-Dose Thalidomide plus Prednisolone Ameliorating Cytopenia in Primary Myelofibrosis. International Journal of Hematology. 2111. 93. 1. 129-131
Wataru Hirata, Toshiaki Shinojima, Kotaro Yokota, Rei Kin, Taketo Yamada, Hirotaka Asakura. A Case of Testicular Cancer in a Long-term Hydranencephaly Survivor with Undescended Testes. IJU Case Reports. 2024
Nishida H, Suzuki R, Nakajima K, Hayashi M, Morimoto C, Yamada T. HDAC inhibition involves CD26 induction on myeloma cells via the c-Myc/Sp1- mediated promoter activation and restores therapeutic resistance to humanized antibody. Cancer Research Communications. 2024. 4. 2. 349-364
Kobayashi E, Kamihara Y, Arai M, Wada A, Kikuchi S, Hatano R, Iwao N, Susukida T, Ozawa T, Adachi Y, et al. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T Cell Therapy for CD26-Expressing T Cell Malignancies. Cells. 2023. 12. 16. 2059
Okatama M, Fujimori K, Sato M, Samata K, Kurita K, Sugiyama H, Ichikawa D, Matsushita M, Suto Y, Iwasaki G, et al. GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase. Cancer Med. 2023

MISC (18件)：

Eriko Komiya-Suyama, Ryo Hatano, Haruna Otsuka, Takumi Itoh, Hiroto Yamazaki, Yasushi Suga, Utako Kimura, Taketo Ya-Mada, Mitsutoshi Tominaga, Kenji Takamori, et al. THE REGULATION OF PRURITUS IN PSORIASIS AND ATOPIC DERMATITIS - A POSSIBLE ROLE FOR CD26/DPPIV. ACTA DERMATO-VENEREOLOGICA. 2017. 97. 8. 1008-1009
Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Rie Murakami, Tami Tsuchiya, Seiji Sato, Kinsei Kou, Minoru Kitago, Yuko Kitagawa, Taketo Yamada, et al. Effects of Obesity and Diabetes on Delta and Pancreatic Polypeptide Cell Mass and the Relative Change among Islet Endocrine Cell Mass in Humans. DIABETES. 2017. 66. A583-A583
Rie Murakami, Yoshifumi Saisho, Kinsei Kou, Seiji Sato, Jun Inaishi, Yuusuke Watanabe, Tami Tsuchiya, Minoru Kitago, Yuko Kitagawa, Taketo Yamada, et al. Relationship between Intrapancreatic Fat Content and Beta- and Alpha-Cell Mass in Humans With and Without Diabetes. DIABETES. 2017. 66. A577-A578
Hiroko Nishida, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada. CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma. BLOOD. 2015. 126. 23
Nobukazu Fujimoto, Kei Ohnuma, Keisuke Aoe, Osamu Hosono, Taketo Yamada, Takumi Kishimoto, Chikao Morimoto. Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma. JOURNAL OF THORACIC ONCOLOGY. 2015. 10. 9. S200-S200

特許 (8件)：

書籍 (10件)：

免疫染色の基礎:抗原賦活法、増感法、ラビット抗体「病理と臨床 38巻臨時増刊号免疫組織化学」
文光堂 2020
免疫染色の基礎:抗原賦活法、増感法、ラビット抗体病理と臨床 38巻臨時増刊号免疫組織化学
文光堂 2020
The Use of the Humanized Anti-CD26 Monoclonal Antibody YS110A as a Novel Targeted Therapy for Refractory Cancers and Immune Disorders.,Advances in Medicine and Biology
Nova Science Publishers 2018
The Use of the Humanized Anti-CD26 Monoclonal Antibody YS110A as a Novel Targeted Therapy for Refractory Cancers and Immune Disorders. Advances in Medicine and Biology
Nova Science Publishers 2018
,The Use of the Humanized Anti-CD26 Monoclonal Antibody YS110A as a Novel Targeted Therapy for Refractory Cancers and Immune Disorders
Nova Science Publishers 2017

講演・口頭発表等 (67件)：

本態性血小板血症患者に生じた、異型巨核球と組織球様細胞の浸潤が目立った皮膚生検の一例
(第102回日本病理学会関東支部学術集会 2024)
リンパ節転移が認められた腫瘍径1cm未満の直腸神経内分泌腫瘍(NET-G2)の1例
(第44回日本癌局所療法研究会 2022)
原発性腹膜癌(高異型度漿液性癌)の一例
(第63回日本臨床細胞学会総会(春期大会) 2022)
CD26陽性がんに対する新規抗体-抗がん剤結合分子ADCの開発
(第111回日本病理学会総会 2022)
Up-regulation of CD26 on multiple myeloma cells by HDAC inhibition augments the efficacy of humanized antibody
(The 63rd AMERICAN SOCIETY OF HEMATOLOGY(ASH) ANNUAL MEETING 2021)

学位 (1件)：

委員歴 (8件)：

全件表示

所属学会 (6件)：

臨床ストレス応答学会 , 日本分子生物学会 , 日本免疫学会 , 日本癌学会 , 日本血液学会 , 日本病理学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

山田 健人